دورية
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
| العنوان: | Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial |
|---|---|
| المؤلفون: | Dewilde, Willem JM, Oirbans, Tom, Verheugt, Freek WA, Kelder, Johannes C, De Smet, Bart JGL, Herrman, Jean-Paul, Adriaenssens, Tom, Vrolix, Mathias, Heestermans, Antonius ACM, Vis, Marije M, Tijsen, Jan GP, van 't Hof, Arnoud W, ten Berg, Jurriën M |
| المصدر: | The Lancet; March 2013, Vol. 381 Issue: 9872 p1107-1115, 9p |
| مستخلص: | If percutaneous coronary intervention (PCI) is required in patients taking oral anticoagulants, antiplatelet therapy with aspirin and clopidogrel is indicated, but such triple therapy increases the risk of serious bleeding. We investigated the safety and efficacy of clopidogrel alone compared with clopidogrel plus aspirin. |
| قاعدة البيانات: | Supplemental Index |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 01406736 1474547X |
|---|---|
| DOI: | 10.1016/S0140-6736(12)62177-1 |